INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 35 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $19,000 | – | 10,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,627,790 | $5,256,000 | 7.39% |
| FT Options LLC | 477,763 | $956,000 | 1.26% |
| Sio Capital Management, LLC | 726,900 | $1,454,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 852,022 | $1,704,000 | 0.43% |
| DAFNA Capital Management LLC | 237,135 | $474,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 401,764 | $804,000 | 0.16% |
| DLD Asset Management, LP | 439,500 | $870,000 | 0.14% |
| Minerva Advisors LLC | 64,759 | $126,000 | 0.07% |
| SHEPHERD KAPLAN KROCHUK, LLC | 36,000 | $72,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 96,435 | $193,000 | 0.04% |